$200K — $250K *
Turning Point Therapeutics is a public, clinical-stage precision oncology company with three molecules in clinical development and one in IND-enabling studies. Our internally discovered investigational drugs are designed to address key limitations of existing cancer therapies. We are applying a highly refined design methodology anchored by SBDD-mediated chemistry and enabling biology expertise to build upon our early portfolio. Our research organization has the exciting task of discovering new investigational molecules and identifying new clinical opportunities for our existing pipeline molecules. We seek talented, committed cancer researchers to join our growing team to develop transformational therapies for cancer patients
The Department of Drug Metabolism & Pharmacokinetics is a key part of the Drug Discovery organization in Turning Point Therapeutics. We are dedicated to the delivery of high-quality clinical candidates, serving an unmet medical need, and within the precision oncology therapeutic R&D focus of the company.
The individual will have an established track record of DMPK project leadership, assay development, and technical problem-solving in early discovery teams.
Experience & Education
EEO & Employment Eligibility
TP Therapeutics is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. TP Therapeutics also complies with all applicable national, state, and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA. TP Therapeutics is an E-Verify employer.
Valid through: 11/21/2021
$250K — $250K+*
17 days ago
$120K — $170K + $25K bonus *
3 days ago